Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03739307 · ClinicalTrials.gov registry record
Characterization & Treatment of Chronic Pain After Moderate to Severe TBI
A clinical trial, sponsored by Craig Hospital.
- Completed
- Registry status
- 3,805
- Enrollment target
NCT03739307: Completed study, sponsored by Craig Hospital.
NCT03739307 is a clinical trial that has completed, run by Craig Hospital. The registered enrollment target is 3,805 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03739307 has completed, sponsored by Craig Hospital.
- COMPLETED
- Registry status
- 3,805 participants
- Enrollment target
Study Summary
This is a five year multi-site, cross sectional, observational study designed to examine chronic pain and pain treatment after moderate to severe TBI.
Primary Outcome
The BPI will be used to determine pain intensity as well as interference related to pain. Intensity of pain is rated by participant on a scale of 0 (no pain) to 10 (pain as bad as you can imagine) when the pain is at it's "worst," "least," "average," and "right now." Pain interference is assessed with seven items using a numeric rating scale ranging from 0 (no interference) to 10 (complete interference). Participants are asked to rate how much pain has interfered with general activity, mood, wal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,805 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2022-10-01 |
What the finished NCT03739307 record still lists
NCT03739307 is an observational study that tracks outcomes without assigning an intervention. Its 3,805 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03739307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03739307 about?
NCT03739307 is a clinical study titled "Characterization & Treatment of Chronic Pain After Moderate to Severe TBI". This is a five year multi-site, cross sectional, observational study designed to examine chronic pain and pain treatment after moderate to severe TBI.
What is the current status of trial NCT03739307?
This trial is currently completed. The enrollment target is 3,805 participants. The study started on 2019-05-20. Estimated completion is 2022-10-01.
Who is sponsoring clinical trial NCT03739307?
This trial is sponsored by Craig Hospital, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI